Skip to main content
Log in

Impact of insulin resistance on contrast induced nephropathy in patients undergoing percutaneous coronary intervention

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Contrast-induced nephropathy (CIN) is a common complication following percutaneous coronary intervention (PCI). Contrast-induced nephropathy after emergency PCI in subjects with insulin resistance (IR) has not been studied before. In this prospective study we determined the relation between IR on CIN, among those undergoing PCI due to acute coronary syndrome. One hundred twenty four consecutive acute coronary syndrome patients with diabetes (N = 44), insulin resistance (N = 38) and normal glycemic metabolism (N = 42) were included in the study. They were all treated with PCI. Pre- and post procedural creatinines were measured and independent predictors of CIN were analyzed. IR was defined as a HOMA level (HOMA-IR = Serum Glucose (mg/dL) X Plasma Insulin (micro unit/mL) / 405 >2.5. Patients with IR or diabetes had significantly higher levels of creatinine after procedure, serum cholesterol, glucose, contrast volume, hospital stay and HOMA. Female gender, frequency of CIN and multivessel disease were also higher in these patients. On the other hand they had significantly lower ejection fraction. Logistic regression analysis showed that HOMA was the single independent risk factor for CIN in patients with acute coronary syndrome treated with PCI. Insulin resistance is an independent risk factor for CIN in patients with acute coronary syndrome treated with PCI. It carries a similar risk with diabetes and proper prophylaxis should be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chong E, Poh KK, Liang S, Tan HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singapore. 2010;39:374–80.

    PubMed  Google Scholar 

  2. Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isono T, Manabe K, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105:624–8.

    Article  PubMed  Google Scholar 

  3. Wang XC, Fu XH, Wang YB, Jia XW, Wu WL, Gu XS, et al. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate. Chin Med J. 2011;124:892–6.

    CAS  PubMed  Google Scholar 

  4. Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007;22:819–26.

    Article  PubMed  Google Scholar 

  5. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.

    Article  PubMed  Google Scholar 

  6. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113:1799–806.

    Article  PubMed  Google Scholar 

  7. Okumura K, Sone T. Risk assessment and prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Intern Med. 2012;51:519–21.

    Article  PubMed  Google Scholar 

  8. Ascaso JF, Pardo S, Real JT, Lorente RI, Preiego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320–5.

    Article  CAS  PubMed  Google Scholar 

  9. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:3160–7.

    Article  PubMed  Google Scholar 

  10. Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol. 2009;98:765–72.

    Article  PubMed  Google Scholar 

  11. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 2006;29:84–93.

    Article  PubMed  Google Scholar 

  12. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett Jr JC. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:115–20.

    Google Scholar 

  13. Clark BA, Kim D, Epstein FH. Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis. 1997;30:82–6.

    Article  CAS  PubMed  Google Scholar 

  14. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant. 2005;20:1542–50.

    Article  PubMed  Google Scholar 

  15. Festa A, Hanley AJ, Tracy RP, D’Agostino Jr R, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003;108:1822–30.

    Article  CAS  PubMed  Google Scholar 

  16. Diamant M, Tushuizen ME. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. Curr Diab Rep. 2006;6:279–86.

    Article  CAS  PubMed  Google Scholar 

  17. Piatti PM, Monti LD, Galli L, Fragasso G, Valsecchi G, Conti M, et al. Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism. 2000;49:748–52.

    Article  CAS  PubMed  Google Scholar 

  18. Andronico G, Mangano M, Ferrara l, et al. In vivo relationship between insulin and endothelin role of insulin-resistance. J Hum Hypertens. 1997;11:63–6.

    Article  CAS  PubMed  Google Scholar 

  19. Skalska A, Gasowski J, Grodzicki T. Antioxidants modify the relationship between endothelin-1 level and glucose metabolism-associated parameters. Metabolism. 2009;58:1229–33.

    Article  CAS  PubMed  Google Scholar 

  20. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005;28:3–11.

    Article  Google Scholar 

  21. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006;67:335–43.

    Article  PubMed  Google Scholar 

  22. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–5.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Ali Elbey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elbey, M.A., Evliyaoglu, O., Simsek, Z. et al. Impact of insulin resistance on contrast induced nephropathy in patients undergoing percutaneous coronary intervention. Int J Diabetes Dev Ctries 34, 40–44 (2014). https://doi.org/10.1007/s13410-013-0140-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-013-0140-4

Keywords

Navigation